Research analysts at StockNews.com started coverage on shares of Milestone Scientific (NYSE:MLSS – Get Free Report) in a report issued on Thursday. The brokerage set a “hold” rating on the stock.
Milestone Scientific Stock Performance
NYSE MLSS opened at $0.68 on Thursday. The firm has a market capitalization of $52.77 million, a price-to-earnings ratio of -6.83 and a beta of 0.90. Milestone Scientific has a one year low of $0.52 and a one year high of $1.35. The company’s 50 day moving average price is $0.69 and its 200 day moving average price is $0.66.
Milestone Scientific (NYSE:MLSS – Get Free Report) last announced its quarterly earnings results on Wednesday, May 15th. The company reported ($0.02) earnings per share for the quarter. Milestone Scientific had a negative return on equity of 93.64% and a negative net margin of 74.50%. The business had revenue of $2.25 million for the quarter.
About Milestone Scientific
Milestone Scientific Inc, a biomedical technology research and development company, patents, designs, develops, and commercializes diagnostic and therapeutic injection technologies, and devices for medical, dental, and cosmetic use in the United States, China, and internationally. The company operates through Dental and Medical segments.
Read More
- Five stocks we like better than Milestone Scientific
- Financial Services Stocks Investing
- Qualcomm Stock: AI-Powered Growth Despite Volatility
- Do ETFs Pay Dividends? What You Need to Know
- Salesforce Stock: Meeting Recap, AI Focus, and Forecast
- 3 Grocery Stocks That Can Help Take a Bite Out of Inflation
- Is CAVA Overextended? A Closer Look at This High-Flying Stock
Receive News & Ratings for Milestone Scientific Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Milestone Scientific and related companies with MarketBeat.com's FREE daily email newsletter.
